Abstract: Cancer has become the disease with the highest incidence and mortality rate. The development of cancer is essentially an abnormal lesion formed by the abnormal growth of cells in local tissues of the body and the process of this abnormal lesion often involves various genetic mutations. With over 20,000 genes in each human body, hundreds are directly related to cancer, and one or several mutations in these cancer-causing genes will greatly increase the probability of cancer development. As technologies in medical and life sciences continue to advance, there are now many ways to screen and diagnose cancer.Summary: Cancer has become the disease with the highest incidence and mortality rate. The development of cancer is essentially an abnormal lesion formed by the abnormal growth of cells in local tissues of the body and the process of this abnormal lesion often involves various genetic mutations. References: https://www.cd-genomics.com/diseasepanel/wp-content/themes/diseasepanel/pdf/main/Why-Cancer-Panels-Stand-Out-for-Cancer-Research.pdf
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Improving the Chemical Synthesis and Performance of Extended-Length Guide RNAs for Genome Editing and Control of Gene Expression
Laurakay Bruhn, Bo Curry, Rob Kaiser, Ben Lunstad, Ryan McCaffrey, Joel Myerson, Subhadeep Roy, Daniel Ryan, Israel Steinfeld, David Taussig, Justin Townsend, Suhani Thakker, Doug Dellinger
Modulating the Activity of CRISPR-Cas with Chemical Modifications in Single-Guide RNAs
Daniel Ryan, David Taussig, Suhani Thakker, Israel Steinfeld, Ben Lunstad, Rob Kaiser, Ryan McCaffrey, Justin Townsend, Patrick Chaffey, Bo Curry, Doug Dellinger, Laurakay Bruhn
The Reasons for Choosing Our Cancer Panels - CD Genomics
Build A Gene Mutation Panel with Non-NGS Technologies - CD Genomics
Efficient Genotyping and Powerful Data Analysis with the Agilent ZAG DNA Analyzer System
Whitney Pike, Solange Borg, Chava Pocernich, and Kyle Luttgeharm